Article
A precision medicine approach for <i>HCN1</i> Developmental and Epileptic Encephalopathy
2024-01-11
Abstract excerpt
Pathogenic variants in HCN1 causing cation leak result in a severe developmental and epileptic encephalopathy (DEE). Current treatment options for patients with HCN1 -DEE are limited and are insufficient to fully address both the seizures and clinical comorbidities of this disorder. Org 34167 is a brain penetrant broad-spectrum HCN channel inhibitor that has completed phase I clinical trials. We used a range of...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 117993b9-71cc-550f-9246-a354f498d2c7
- DOI
- 10.1101/2024.01.09.574555
